2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Castration Levels of Testosterone: new trials by email Literature Review of Castration Levels of Testosterone trials Research Report on Castration Levels of Testosterone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Abiraterone Acetate, Androgen deprivation therapy, Cabazitaxel - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma | Phase 2 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 223 | 2018-04-26 | 2026-10-06 |
| Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Abiraterone Acetate, Apalutamide, Cabazitaxel - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 196 | 2016-05-18 | 2026-09-14 |
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
Abiraterone Acetate (2) · Prednisone (2) · XRP6258 (2) · cabazitaxel (2) · Androgen Antagonists (1) · CTLA-4 Antigen (1) · Carboplatin (1) · Ipilimumab (1) · apalutamide (1) · deltacortene (1) · prednylidene (1)
ECOG-ACRIN Cancer Research Group (1) · M.D. Anderson Cancer Center (1)
United States (2) · Puerto Rico (1)
Ana Aparicio (1) · Christos Kyriakopoulos (1)
U10CA180820 (1)